# NPPA fixes Cholecalciferol 7000 IU tablet price at Rs 8.93 2026-11-06T21:51:19+00:00 | Governance | Indian Opinion Desk Corroboration: 1 independent outlet The National Pharmaceutical Pricing Authority (NPPA) has set the retail price of Cholecalciferol 7000 IU Tablets at Rs 8.93 per tablet, excluding GST. The price applies to the formulation manufactured by Windlas Biotech Limited and marketed by Eris Lifesciences Limited. The order, issued under the Drugs (Prices Control) Order 2013, uses powers under paragraphs 5, 11 and 15. The manufacturer must ensure the retail price does not exceed the notified amount and may add GST only if actually paid or payable to the government. Non-compliance will make the manufacturer liable to deposit the overcharged amount with interest under the DPCO 2013 and the Essential Commodities Act 1955. The manufacturer must issue a price list in Form-V to the NPPA and submit copies to the State Drug Controller and dealers. ## Indian Opinion Analysis The NPPA's price cap on a single-source vitamin D supplement directly controls the cost for patients who depend on this high-dose formulation. The notification leaves unresolved how the price will affect availability: the cap applies only to Windlas Biotech and Eris Lifesciences, and other manufacturers of the same strength are not covered. Manufacturers must comply with price display and reporting rules, and the NPPA can recover overcharged amounts with interest if the ceiling is breached. ## Coverage - medicaldialogues.in Straightforward regulatory notification with no framing slant This brief was synthesised by AI from the source linked above. Tags: DPCO 2013, Eris Lifesciences, NPPA, Windlas Biotech Canonical: https://indianopinion.org/nppa-fixes-cholecalciferol-7000-iu-tablet-price-at-rs-8-93/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/nppa-fixes-cholecalciferol-7000-iu-tablet-price-at-rs-8-93/#story-in-brief How this brief was made: an AI model read the report linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/